Article

Trump's Budget will Gut Cancer Research

Author(s):

Trump proposed budget cuts to National Institutes of Health, National Cancer Institute and Medicaid

We all know that there is a cure for cancer, and it’s called money. Over the past two decades the funds allocated for cancer research by the government have been consistently increased but not nearly enough for researchers to spend the time and hours in the lab to beat this stealthy disease — that now kills thousands of Americans a day.

That is the Titanic going down daily. Two days of cancer loss are the equivalent to the number of people we lost when the twin towers fell. Cancer kills men, women and children without discriminating.

And now Trump wants to severely cut funding to federal agencies that support biomedical research and Medicaid for Fiscal Year 2018, including 20 percent proposed funding cut for the national Institutes of Health (NIH), more cuts proposed cut for the National Cancer Institute (NCI), and reducing Medicaid funding by more than $800 billion.

“Such extreme reductions to programs that are critical to research will fundamentally damage our nation’s progress in treating patients and will irreversibly harm our nation’s already fragile biomedical research infrastructure,” says Daniel F. Hayes, president of the American Society of Clinical Oncology (ASCO) in a statement released this week. ASCO, the largest organization of its kind in the world, represents some 40,000 oncology professionals.

The cuts come at a time when the outlook for cancer patients has improved to the point that there are 15 million cancer survivors in the U.S. compared to seven million in 1991 and three million in 1971. Research has allowed treatments to become targeted to a patient’s cancer type, genetics, age and health status.

Government funding provides the basic research that are the keys to many of the findings about cancer’s genetics and biology.

Federal research funding also provides economic strength and scientific leadership, supporting more than 400,000 jobs and contributing $60 billion in economic activity annually, according to facts included in an ASCO release.

“Biomedical research is one of our nation’s best investments, and we urge Congress to build on the momentum they have created and provide robust increases for NIH in FY 2018,” Hayes says. “Our biomedical research infrastructure is vital to sustaining the health and safety of our citizens. If allowed to crumble, it will take decades to rebuild.”

What can be done about this? The American people need to raise an outcry that their lives are more valuable than a wall.

Write your elected officials and let them know how you feel. That not only should Trump not cut funding, he needs to increase it.

Related Videos
1 expert is featured in this series.
Dr. Alan Tan is the GU Oncology Lead at the Vanderbilt-Ingram Cancer Center in Nashville, Tennessee, as well as an associate professor in the Division of Hematology/Oncology at Vanderbilt University Medical Center and GU Executive Officer with the Alliance for Clinical Trials in Oncology.
Bald Doctor.
Dr. David A. Braun, an Assistant Professor of Medicine, Medical Oncology, and a Louis Goodman and Alfred Gilman Yale Scholar, at the Yale School of Medicine, as well as a member of the Center of Molecular and Cellular Oncology at Yale Cancer Center, in New Haven, Connecticut
1 expert is featured in this series.
Dr. Anna Arthur is the Director of the Medical Nutrition Science Program, as well as a tenure-track Assistant Professor in the Department of Dietetics and Nutrition at the University of Kansas Medical Center.
Dr. Ritu Salani, the Director of Gynecologic Oncology at the University of California, Los Angeles (UCLA), UCLA Health, and a board-certified gynecologic oncologist.
Image of Dr. Scott Kopetz
Image of Dr. Susumu Hijoka
1 expert is featured in this series.
Related Content